Skip to content

Immune Status in Solid Organ Transplantation

Evaluation of Predictors of Immune Status in Solid Organ Transplantation

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01070901
Enrollment
20
Registered
2010-02-18
Start date
2010-05-31
Completion date
2012-03-31
Last updated
2013-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Organ Transplants

Brief summary

Immunosuppressive therapy protocols in solid organ transplantation are rudimentary, differ by transplant center and no practical strategies are available to guide an individuals' response to immune suppression. In this study we will conduct research to assess immunologic status in solid organ transplant recipients, predicting immune reconstitution and outcomes after transplant to better guide the use of immunosuppressive medications.

Interventions

None listed

Sponsors

Astellas Pharma Inc
CollaboratorINDUSTRY
Dartmouth-Hitchcock Medical Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Impending kidney transplant * Age \>18 * Able to provide informed consent and comply with the study procedures

Exclusion criteria

* Age\<18 * Concomitant illness, which by decision of investigator, may compromise the ability to perform this trial

Design outcomes

Primary

MeasureTime frame
Immune Markers0, 3, 6, 9, 12 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026